Stay updated on Abscopal Effect in HL Clinical Trial
Sign up to get notified when there's something new on the Abscopal Effect in HL Clinical Trial page.

Latest updates to the Abscopal Effect in HL Clinical Trial page
- Check6 days agoChange DetectedThe record for a Phase 2 Hodgkin lymphoma study is displayed, including its treatment plan, eligibility criteria, outcome measure, locations, and study dates. The study is listed as active but not recruiting.SummaryDifference35%

- Check13 days agoChange DetectedThe displayed site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page. The site revision identifier also changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details. This indicates access is blocked and the usual study information cannot be viewed in this state.SummaryDifference15%

- Check62 days agoChange DetectedThe page revision identifier was updated from v3.6.6 to v3.7.0, indicating a new build of the page. This is a background update and does not modify study details or displayed information.SummaryDifference0.1%

Stay in the know with updates to Abscopal Effect in HL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abscopal Effect in HL Clinical Trial page.